| Oncology | Lifetime | 897 | US 489 | 98.03 |
| Oncology | 2021-2025 | 207 | US 88 | 98.37 |
| Public, Environmental and Occupational Health | 2021-2025 | 394 | US 145 | 96.42 |
| Genetics | 2021-2025 | 290 | US 114 | 92.57 |
| Pediatrics, Perinatology and Child Health | 2021-2025 | 449 | US 179 | 89.24 |
| Cancer Research | 2021-2025 | 316 | US 119 | 81.22 |
| Male Breast Health Studies | Lifetime | 11 | US 5 | 97.73 |
| Cancer survivorship and care | Lifetime | 250 | US 131 | 98.19 |
| BRCA gene mutations in cancer | Lifetime | 261 | US 145 | 98.07 |
| Cancer Treatment and Pharmacology | Lifetime | 749 | US 367 | 98.03 |
| Breast Cancer Treatment Studies | Lifetime | 721 | US 326 | 97.92 |
| Childhood Cancer Survivors' Quality of Life | Lifetime | 659 | US 352 | 97.22 |
| Chemotherapy-related skin toxicity | Lifetime | 102 | US 57 | 96.02 |
| Cancer Risks and Factors | Lifetime | 419 | US 218 | 97.19 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 277 | US 143 | 94.71 |
| Family Support in Illness | Lifetime | 560 | US 267 | 95.15 |
| Advanced Breast Cancer Therapies | Lifetime | 674 | US 286 | 94.65 |
| Cancer and Skin Lesions | Lifetime | 806 | US 375 | 94.61 |
| Cancer-related cognitive impairment studies | Lifetime | 344 | US 193 | 93.07 |
| Economic and Financial Impacts of Cancer | Lifetime | 789 | US 503 | 92.88 |
| Cancer survivorship and care | 2021-2025 | 49 | US 18 | 98.30 |
| BRCA gene mutations in cancer | 2021-2025 | 49 | US 25 | 97.76 |
| Childhood Cancer Survivors' Quality of Life | 2021-2025 | 132 | US 82 | 97.19 |
| Male Breast Health Studies | 2021-2025 | 3 | US 3 | 93.96 |
| Cancer Risks and Factors | 2021-2025 | 63 | US 33 | 95.90 |
| Cancer Treatment and Pharmacology | 2021-2025 | 206 | US 70 | 95.95 |
| Reproductive Biology and Fertility | 2021-2025 | 395 | US 58 | 94.14 |
| Cancer-related cognitive impairment studies | 2021-2025 | 84 | US 41 | 92.60 |
| Breast Cancer Treatment Studies | 2021-2025 | 519 | US 178 | 94.46 |
| Economic and Financial Impacts of Cancer | 2021-2025 | 352 | US 221 | 90.93 |
| Chemotherapy-related skin toxicity | 2021-2025 | 52 | US 22 | 87.88 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 230 | US 91 | 84.87 |
| Global Cancer Incidence and Screening | 2021-2025 | 836 | US 359 | 88.95 |
| Estrogen and related hormone effects | 2021-2025 | 356 | US 124 | 83.39 |
| Advanced Breast Cancer Therapies | 2021-2025 | 928 | US 317 | 83.97 |
| Family Support in Illness | 2021-2025 | 812 | US 257 | 77.31 |
| Chemotherapy-induced cardiotoxicity and mitigation | 2021-2025 | 530 | US 154 | 77.20 |
| Reproductive Health and Technologies | 2021-2025 | 849 | US 357 | 79.41 |
| Breast Implant and Reconstruction | 2021-2025 | 838 | US 335 | 75.67 |
| Nausea and vomiting management | 2021-2025 | 877 | US 113 | 59.70 |
| Pathogenesis and Treatment of Hiccups | 2021-2025 | 151 | US 38 | 37.62 |